find the latest legal job
Senior Associate - Litigation & Dispute Resolution
Category: Litigation and Dispute Resolution | Location: Melbourne CBD & Inner Suburbs Melbourne VIC
· Come work for a firm ranked in Lawyers Weekly Top 25 Attraction Firms
View details
Associate - Workplace Relations & Safety
Category: Industrial Relations and Employment Law | Location: Brisbane CBD & Inner Suburbs Brisbane QLD
· Employer of choice · Strong team culture
View details
Freelance Lawyers
Category: Banking and Finance Law | Location: All Perth WA
· Freelance opportunities through Vario from Pinsent Masons
View details
Freelance Lawyers
Category: Other | Location: All Adelaide SA
· • Qualified lawyer with a strong academic background
View details
Freelance Lawyers
Category: Other | Location: All Melbourne VIC
· • Qualified lawyer with a strong academic background
View details
DibbsBarker acts on rare tender offer process

DibbsBarker acts on rare tender offer process

DibbsBarker has recently advised Start-up Australia Ventures Pty Ltd (Start-up), a specialist venture capital company, on its invitation to tender for the purchase of its 28 per cent stake in…

DibbsBarker has recently advised Start-up Australia Ventures Pty Ltd (Start-up), a specialist venture capital company, on its invitation to tender for the purchase of its 28 per cent stake in drug discovery company Bionomics Limited (BNO).

This innovative tender offer, for a stake currently valued at around $29 million, was announced by Start-up to the ASX on 10 November 2010.

The tender offer is being implemented under rarely-used ASIC Regulatory Guide 102, which enables the Australian Securities & Investments Commission (ASIC) to provide tenderers relief from the takeover provisions that normally limit the acquisition of more than 20 per cent of the voting shares in a company.

Effectively, the relief enables a tenderer to submit a tender offer for and, if successful, secure a stake of more than 20 per cent without the requirement for majority shareholder approval, so long as it makes a full takeover bid for the company at the tender price immediately after securing the stake, thus protecting the position of other shareholders.

DibbsBarker assisted Start-up throughout this process, which included the preparation of tender documents and obtaining indicative advice from ASIC as to the prospects of granting relief to tenderers.

DibbsBarker special counsel Michael Hodgson, who specialises in corporate M&A transactions, advised Start-up on this offer. He said the main attraction of this process for Start-up was that it enabled them to put their whole stake up for sale without raising takeover issues.

"Start-up were keen to exit and realise their investment, and this process ensures that minority shareholders have the option to receive the same price as they do, including any control premium," said Hodgson.

Hodgson also said this tender process was particularly suited to institutional investors holding significant parcels in small to medium-listed companies who believe the company's value is not fully reflected in the share price and seek to realise their investment.

"In the post-GFC environment, there are plenty of companies - including in the life sciences space - that have not been rewarded by the local market for their progress and where international investors could provide capital and support to spur further growth.

"As such, we would recommend that venture capitalists and other institutional investors in these types of companies give consideration to using this tender process to realise their investment in a way that avoids the uncertainty, delay and expense of shareholder approval and potentially benefits all shareholders."

According to DibbsBarker, the Start-up proposal is only the second of its kind in Australia in recent years after the Regulatory Guide was introduced in 1995.

In 2007, a group of shareholders in timber supplier Auspine invited tenders for a 25 per cent stake, ultimately leading to Auspine being taken over by Gunns Limited.

Last year, DibbsBarker advised Start-up in its sale of shares in Arana Therapeutics Limited to US pharmaceutical company Cephalon, Inc.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

DibbsBarker acts on rare tender offer process
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
Oct 20 2017
Podcast: One of law’s most infamous alumni – in conversation with Julian Morrow
In this episode of The Lawyers Weekly Show, Melissa Coade is joined by The Chaser’s Julian Morrow....
Oct 20 2017
High Court overturns ‘excessive’ anti-protest legislation
Bob Brown’s recent victory in the High Court over the Tasmanian government was a win for fundament...
Oct 20 2017
Changes to Australian citizenship laws blocked
Attempts to beef up the requirements to obtain Australian citizenship were thwarted this week, after...
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...